David versus Goliath: Oshkosh Wins Yet Another Big Contract
Aug 28th, 2009 | By Andrew Snyder | Category: Stock Market Investing500% gains in six months is an astonishing accomplishment. How long can Oshkosh continue to outbid its fierce competitors?
Just when most investors believe it shares had topped out and were ready to level off, OshKosh (NYSE:OSK) goes and wins yet another huge contract.
When I first started tracking the heavy-equipment manufacturer late last year, shares were going for just $5.76. After a quick, in-and-out recommendation, readers that followed my recommendation locked in gains of 35%.
Not bad, but we should have held our shares.
As I write, those same shares are trading for over $34.00, good for gains of just shy of 500%, up 25% today alone.
Obviously, when a stock surges by that much in that short of a period, the market made some forecasting errors. In the case of Oshkosh, nobody could have predicted the company’s ability to deliver a knockout right hook to its competition.
After all, Oshkosh has some fierce competition, chiefly BAE Sytems.
David versus Goliath
Over the six months, shares have soared based on the news Oshkosh was awarded a billion-dollar contract from the Pentagon. While today’s news that the company locked in yet another $280 million worth of Army spending is not nearly the size of the previous deal, it highlights the fact that BAE is having one tough time beating the deals Oshkosh is putting on the table.
With several major contracts under the company’s belt, investors are beginning to realize Oshkosh may no longer be a small, niche player.
Thanks to over $1.3 billion in government-funded revenues so far this year, Oshkosh appears to be building enough momentum and financial stability to turn the company into a fantastic growth story.
As for BAE, the top-line figures the Street is putting onto Oshkosh’s income statement are being pulled off the British firm’s valuation. Shares of BAE were down by over 5% today.
While we missed out on spectacular triple-digit gains, I am not going to complain one bit.
First, we locked in 35% gains in the eye of a nasty recession. Next, the market’s recent action proves I was not the only one limiting the company’s growth potential.
And finally, who is going to complain when an American company is locking in jobs building trucks for American forces?
Here’s a tip of my hat to Oshkosh and its winning ways. Keep up the good work.
Source: David versus Goliath: Oshkosh Wins Yet Another Big Contract
Advertisement
At Hot Stock Confidential , we've averaged over 32% gains in just 26 trading days
42% on Nymox Pharmaceutical Corp....
23% on Emergent BioSolutions Inc....
38% on the first half of our position in a U.S. refiner...
26.68% on Synta Pharmaceuticals...
How's your favorite financial newsletter working out for you?
Hot Stock Confidential = Damn Good Stocks.
Learn more...